SB

Samsara BioCapital Portfolio holdings

AUM $969M
1-Year Est. Return 134.49%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+134.49%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$497M
AUM Growth
+$496M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$39.9M
2
+$24M
3
+$13M
4
TERN icon
Terns Pharmaceuticals
TERN
+$10.9M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$8.66M

Top Sells

1
+$7.26M
2
+$6.65M
3
+$2.22M
4
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$2.17M
5
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$1.27M

Sector Composition

1 Healthcare 97.77%
2 Financials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$66.9M 13.48%
2,034,703
2
$49.2M 9.91%
3,168,388
3
$43.9M 8.83%
1,565,529
+147,000
4
$39M 7.85%
+77,701
5
$38.1M 7.68%
167,558
6
$25.8M 5.19%
1,022,612
-340,000
7
$24.3M 4.89%
+36,873
8
$16.8M 3.38%
146,259
9
$14.8M 2.98%
640,688
+237,000
10
$14.8M 2.97%
218,920
11
$14.7M 2.95%
2,372,476
12
$12.5M 2.52%
169,852
-92,720
13
$10.9M 2.2%
+497,555
14
$9.39M 1.89%
+826,422
15
$9.29M 1.87%
1,111,112
16
$8.72M 1.76%
95,318
17
$7.69M 1.55%
+831,625
18
$7M 1.41%
35,349
19
$6.08M 1.22%
396,835
-78,108
20
$5.56M 1.12%
500,000
21
$5.47M 1.1%
30,160
22
$5.46M 1.1%
764,403
-309,882
23
$4.99M 1%
507,041
+501,818
24
$4.96M 1%
549,250
+115,000
25
$4.87M 0.98%
166,250
1
2